An opioid deficit in borderline personality disorder: Self-cutting, substance abuse, and social dysfunction

American Journal of Psychiatry

Volumn 167, Issue 8, 2010, Pages 882-885

  New, Antonia S ^a   Barbara, Stanley ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; BUPRENORPHINE; CARBON 11; CARFENTANIL; METENKEPHALIN; MU OPIATE RECEPTOR; OPIATE; RADIOLIGAND;

AUTOMUTILATION; BORDERLINE STATE; BRAIN; DISEASE CLASSIFICATION; EDITORIAL; EMOTION; HEALTH CARE UTILIZATION; HUMAN; MENTAL HEALTH CARE; MODEL; MOOD; MORBIDITY; MORTALITY; NEUROSIS; OPIATE ADDICTION; PERSONALITY DISORDER; PREFRONTAL CORTEX; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL THEORY; RECEPTOR BINDING; SOCIAL DISABILITY; SUBSTANCE ABUSE; SUICIDE; SYMPTOM; WITHDRAWAL SYNDROME;

BORDERLINE PERSONALITY DISORDER; HUMANS; OPIOID PEPTIDES; OPIOID-RELATED DISORDERS; SELF MUTILATION; SOCIAL ADJUSTMENT; SUBSTANCE-RELATED DISORDERS;

EID: 77955362435     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2010.10040634     Document Type: Editorial

References (12)

1. Grant BF, Chou SP, Goldstein RB, Huang B, Stinson FS, Saha TD, Smith SM, Dawson DA, Pulay AJ, Pickering RP, Ruan WJ: Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2008; 69:533-545 (Pubitemid 351792327)
2. Zanarini MC, Frankenburg FR, Khera GS, Bleichmar J: Treatment histories of borderline inpatients. Compr Psychiatry 2001; 42:144-150
3. Prossin AR, Love TM, Koeppe RA, Zubieta J-K, Silk KR: Dysregulation of regional endogenous opioid function in borderline personality disorder. Am J Psychiatry 2010; 167:925-933
4. Stanley B, Siever LJ: The interpersonal dimension of borderline personality disorder: toward a neuropeptide model. Am J Psychiatry 2010; 167:24-39
5. Stanley B, Sher L, Wilson S, Ekman R, Huang YY, Mann JJ: Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters. J Affect Disord 2010; 124:134-140
6. Schmahl C, Meinzer M, Zeuch A, Fichter M, Cebulla M, Kleindienst N, Ludascher P, Steil R, Bohus M: Pain sensitivity is reduced in borderline personality disorder, but not in posttraumatic stress disorder and bulimia nervosa. World J Biol Psychiatry 2010; 11(2, part 2):364-371
7. Sansone RA, Whitecar P, Wiederman MW: The prevalence of borderline personality among buprenorphine patients. Int J Psychiatry Med 2008; 38:217-226
8. Panksepp J, Herman BH, Vilberg T, Bishop P, DeEskinazi FG: Endogenous opioids and social behavior. Neurosci Biobehav Rev 1980; 4:473-487
9. Kennedy SE, Koeppe RA, Young EA, Zubieta JK: Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch Gen Psychiatry 2006; 63:1199-1208
10. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS: Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001; 293:311-315 (Pubitemid 32694749)
11. Gunderson JG: Disturbed relationships as a phenotype for borderline personality disorder (commentary). Am J Psychiatry 2007; 164:1637-1640 (Pubitemid 350205336)
12. Brodsky BS, Groves SA, Oquendo MA, Mann JJ, Stanley B: Interpersonal precipitants and suicide attempts in borderline personality disorder. Suicide Life Threat Behav 2006; 36:313-322